What is CorDynamics?
CorDynamics operates as a premier preclinical Contract Research Organization (CRO) with a specialized focus on cardiovascular drug discovery and safety. The company provides a comprehensive suite of expert services, leveraging advanced research models and techniques to address critical areas such as heart failure, atrial fibrillation, and thrombosis. CorDynamics is dedicated to generating scientifically rigorous data to advance cardiovascular therapeutics and expedite clinical development, serving a global clientele within the pharmaceutical and biotechnology industries.
How much funding has CorDynamics raised?
CorDynamics has raised a total of $462K across 2 funding rounds:
Debt
$150K
Debt
$312K
Debt (2020): $150K with participation from PPP
Debt (2021): $312K led by PPP
What's next for CorDynamics?
With the recent infusion of capital in a large-scale late-stage funding round, CorDynamics is poised for accelerated growth and enhanced service offerings. This strategic investment is expected to fuel further expansion of its preclinical research capabilities, potentially enabling the company to broaden its service portfolio in cardiovascular safety and drug discovery. The company's focus on providing timely and reliable data positions it to capitalize on emerging opportunities in therapeutic development.
See full CorDynamics company page
